'[T]he quantity of drugs attributed to a defendant need not be foreseeable to him when he personally participates, in a direct way, in a jointly undertaken drug transaction,' pursuant to U.S. v. Chalarca, a 1996 decision of the U.S. Court of Appeals for the 2nd Circuit.
VIEW FULL CASE